Close Menu

NEW YORK – PHIX Genomics is a new clinical genomics diagnostics company that aims to be operational in the Philippines by the second quarter of next year, serving the country with a menu of tests that will include cancer profiling, pharmacogenomic, inherited disease screening, and other assays.

Clinical genomics is just one business area for PHIX, which also intends to sell genomic tools and introduce a variety of agriculture and lifestyle-focused tests to the Southeast Asian country.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.